Professional Documents
Culture Documents
27 October 2019
Running Head: MARIJUANA AND MAiD 2
Practice guidelines for Advanced Practice Registered Nurses (APRN) are dictated by a
variety of state, federal, and institutional bodies. Controversial legislation like medical marijuana
programs (MMP) and medical aid in dying (MAiD) can impact practice. They may also present
additional ethical and moral considerations. Clinicians must be aware of how new laws such as
The tenuous legality and novelty of medical marijuana presents challenges to APRNs that
must be considered. Medical marijuana has gained increasing support, with 33 states legalizing
Substances Act of 1970). Information regarding potential drug interactions, side effects, and
efficacy of medical marijuana is limited. Clinicians face potential prosecution for contravening
nabilone. The safety and efficacy of these drugs is known, and there is current research
supporting use for specific conditions, such as chemotherapy-induced nausea and vomiting
(Badowski, 2017). In order to make the optimal recommendation for patients, clinicians need
In order to minimize risk regarding the legal status of medical marijuana, APRNs must
keep current with legislation, both at the federal and state levels. Each MMP is unique to the
Running Head: MARIJUANA AND MAiD 3
state in which it was enacted, and APRNs should be familiar with the MMP for their state. It
outlines specifics of the program, such as qualifying conditions and who is authorized to certify
(National Council of State Boards of Nursing, 2018). The ethical decision to participate,
Medical Aid in Dying (MAiD) is another controversial area with increased public
support, with passage of laws in nine states over the last 20 years (Span, 2019). Hospice and
palliative care APRNs are the most impacted by this, as patients with terminal illness may view
currently restricted, potentially severing an active therapeutic relationship. There are also ethical
considerations for APRNs when working with patients who have requested MAiD.
MAiD statutes only allow physicians to serve as certifying clinicians, qualified second
opinions, and providers of lethal medication doses. However, there are jurisdictions outside the
United States that have expanded practice guidelines to include Nurse Practitioners and
Physician Assistants (Stokes, 2017). As more legislation is passed and research becomes more
readily available, APRNs may play a broader role in MAiD in the US.
There are also ethical implications for this legislation. Historically, the American Nurses
Association opposed MAiD, and the official position statement indicated that MAiD was a
violation of nursing ethics (2013). With the shift in public opinion, the ANA released an updated
position statement in 2019 that takes a more neutral stance. It now includes language that
supports the need to be educated and unbiased when caring for patients who request MAiD.
(American Nurses Association, 2019). This new position helps provide professional guidance
for APRNs, and allows clinicians more freedom to practice according to conscience.